SciSparc (NASDAQ:SPRC) Stock, Quote.Headers.trade-ideas

SciSparc

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

1-14

Cannabis

News

Psychedelics

Health Care

Press Releases

CMND

SPRC

Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.

Clearmind Medicine Files International Patent For Ibogaine Combination Therapy

movers image

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADGM

ALLR

APVO

AVGR

BBLG

CNEY

DRMA

GDHG

GLMD

HCWC

INTC

MYNA

NCPL

NKGN

OPTT

SMSI

TNON

WHLR

ZVSA

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

ABIO

AFRM

APLD

BCDA

BSLK

FIVE

JBDI

MESO

NTNX

OKTA

PSTG

QNTM

TCBP

TOVX

Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

SciSparc Ltd

B of A Securities analyst Rafe Jadrosich maintains Dream Finders Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFH#NYSE">DFH</a>) with a Neutral and raises the price target from $35 to $38.

Price Target

Analyst Ratings

B of A Securities Maintains Neutral on Dream Finders Homes, Raises Price Target to $38

T-Mobile US Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) shares were climbing on Thursday, after the company <a href="https://www.benzinga.com/markets/equities/24/09/40939403/t-mobile-surpasses-2021-capital-markets-day-goals-sets-new-ambitions-boosts-dividend-more">unveiled a three-year AI-focused plan</a>.
Here are some key takeaways from the company's Capital Markets Day in San Francisco.
<h1 class="wp-block-heading">Scotiabank On T-Mobile US</h1>
Analyst Maher Yaghi reiterated a Sector Outperform rating while raising the price target from $197.00 to $215.50.
T-Mobile detailed its growth plans for the next three years, the financial output of which "looks impressive with continuation of leading wireless subscriber loading, service revenue growth and FCF growth compared to US peers," Yaghi said in a note. 
The plan is focused on improving customer experience, unlike many telecom companies that have made cost-cutting their main focus, he added.
"We believe the expected 5% CAGR service revenue growth up to 2027 and the 8% Adj. FCF growth metrics, which do not include any of the pending acquisitions already announced, should support further stock upside," the analyst wrote. This should generate "sizable capital returns to shareholders," while still leaving the company with around $20 billion in cash "to further de-lever the balance sheet or undertake additional M&amp;A," he further stated.
<h1 class="wp-block-heading">Oppenheimer On T-Mobile US</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59282ae6290fa7000185325b/timothy-horan">Analyst Timothy Horan</a> maintained an Outperform rating while lifting the price target to $215.
"The company has transformed to the leading wireless carrier in spectrum depth, network performance, growth, and FCF margins, and is taking the lead in GenAI on both networks and CX," Horan wrote in a note. The company aims to "reduce inbound calls by 75% and resolve 100% of upgrades and 50%-plus of activations digitally," he added. &nbsp;
T-Mobile plans to use OpenAI for its upcoming IntentCX platform to increase customer engagement, the analyst stated. The company has also partnered with NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) to "accelerate the development of AI-RAN," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">KeyBanc Capital Markets On T-Mobile US</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59f8cd40efacff000111b43b/brandon-nispel">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59f8cd40efacff000111b43b/brandon-nispel">Brandon Nispel</a> reaffirmed an Overweight rating and price target of $230.
T-Mobile&#8217;s 2027 guidance has "a number of upside levers from the contribution of Metronet, Lumos and US Cellular, plus the execution of &#8216;Hero Projects&#8217; and growth in underpenetrated Small Markets and Rural, Business and now First Responders," Nispel said.
T-Mobile has set targets that would make it "a larger Home Broadband provider by customer count" than both AT&amp;T Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) and Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), which highlights that the company is "not at a strategic disadvantage despite lower Fiber home passed targets," the analyst stated.
<h1 class="wp-block-heading">Goldman Sachs On T-Mobile US</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5805f8a2846faa000106ab15/james-schneider">Analyst James Schneider</a> maintained a Buy rating and price target of $205.
T-Mobile has "ambitious targets" for broadband growth" and announced both revenue and cost initiatives around AI, Schneider said. Management is guiding to 2027 Service Revenue of $75-$76 billion and adjusted EBITDA of $38-$39 billion, ahead of consensus of $74.2 billion and $37.9 billion, respectively, he added.
While the company's financial guidance was "broadly in line with elevated expectations heading into the event," it was modestly disappointing for capital returns, the analyst stated. "We came away from the event with increased confidence in the sustainability of T-Mobile's growth trajectory, particularly with respect to its broadband initiatives," he further wrote.
<h1 class="wp-block-heading">RBC Capital Markets On T-Mobile US</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846ee55ee7bf6000154d12b/jonathan-atkin">Analyst Jonathan Atkin</a> reiterated an Outperform rating and price target of $200.
The company announced a new shareholder return program through 2027 worth $80 billion, Atkin said. It will use $10 billion to "fund all announced transaction, including USM, Lumos, Metronet, and spectrum payments," he stated.
T-Mobile has allocated $50 billion for share buybacks and dividends, "with dividend per share growth in the double digits," the analyst stated. He added, however, that $20 billion has been set aside as "a buffer for acquisitions and deleveraging apart from buybacks."
TMUS Price Action: Shares of T-Mobile US had risen by 1.80% to $200.22 at the time of publication on Thursday.
Read More:   • <a href="https://www.benzinga.com/markets/equities/24/09/40932937/apple-iphone-16-selling-at-a-greater-rate-than-last-year-says-t-mobile-ceo-amid-reports-of-lower">Apple iPhone 16 Selling At A &#8216;Greater Rate Than Last Year,&#8217; Says T-Mobile CEO Amid Reports Of Lower Demand: &#8216;People Are Buying Pros, They&#8217;re Buying Maxs…They&#8217;re Buying Up The Food Chain&#8217;</a>
Photo: Viewimage on Shutterstock

Analyst Color

Reiteration

NVDA

TMUS

T-Mobile Announces 3-Year AI Plan Analyst Says Could Mean 'Sizable Capital Returns To Shareholders'

WIIM

CHWY

ETSY

KIRK

PLCE

SFIX

Shares of companies in the retail industry are trading higher following the Fed's policy decision to cut rates, which could support consumer spending. Additional, the industry may be moving on continued strength following strong August retail sales data.

<a href="https://www.youtube.com/watch?v=uxd8kAq8Uxw" title="https://www.youtube.com/watch?v=uxd8kAq8Uxw">https://www.youtube.com/watch?v=uxd8kAq8Uxw</a>

Macro Notification

Politics

General

LIVE: Biden delivers remarks at the Economic Club of Washington, D.C.

B of A Securities analyst Ronald Epstein maintains Heico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>) with a Buy and raises the price target from $250 to $285.

B of A Securities Maintains Buy on Heico, Raises Price Target to $285

Jefferies analyst Brian Tanquilut maintains RadNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDNT#NASDAQ">RDNT</a>) with a Buy and raises the price target from $75 to $80.

RDNT

Jefferies Maintains Buy on RadNet, Raises Price Target to $80

Northland Capital Markets analyst Greg Gibas maintains Trupanion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) with a Market Perform and raises the price target from $35 to $45.

TRUP

Northland Capital Markets Maintains Market Perform on Trupanion, Raises Price Target to $45

CleanSpark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) shares are trading higher Thursday amid strength in Bitcoin as investors digest the first interest rate cut from the <a href="https://www.benzinga.com/news/earnings/24/09/40934972/wall-street-primed-for-relief-rally-as-traders-eye-jobless-claims-fedex-earnings-after-feds-50-basi">Federal Reserve in four years.</a>
The Details: CleanSpark shares are climbing amid a broad market rally as investors digest the Fed's interest rate cut which marked the first in more than four years. Lower interest rates increase the attractiveness of risk assets like stocks and cryptocurrencies.&nbsp;
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is trading above the $63,000 level Thursday and saw <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40926729/bitcoin-spikes-above-61-000-as-fed-implements-50-bps-rate-cut">increased trading</a> following the Federal Reserve&#8217;s surprise decision, which exceeded the anticipated 25 basis point cut.&nbsp;
Read Next: <a href="https://www.benzinga.com/fintech/24/09/40928342/what-happened-with-sofi-stock-today">What Happened With SoFi Stock Today?</a>
"These markets should benefit from the formalization of the Fed&#8217;s dovish shift. Our long-term investment thesis for Bitcoin remains intact, and regardless of the near-term direction of monetary policy, BTC is well-positioned for growth as institutional adoption continues to gain momentum," Hashdex&#8217;s CIO Samir Kerbage wrote in a note sent to Benzinga.
<h3 class="wp-block-heading">CLSK Stock Prediction 2024:</h3>
Cleanspark&#8217;s revenue growth in FY23 was 20.22%, reflecting the influence of various factors including the macroeconomic environment, demand for its products and services, and its position relative to competitors. This growth is a critical indicator for investors assessing the company&#8217;s future prospects.
Some macro factors that could impact the company's performance in the next year include higher interest rates, progress on reeling in inflation and labor market strength. The Fed's benchmark rate is currently at 5.33%, while PPI recently came in at 0.2%, growing 1.7% from last year. The unemployment rate was most recently reported as 4.2%.
An investor should pay attention to economic conditions to decide whether they think the macro environment is positive or negative for Cleanspark stock. For real time economic data and breaking market updates, <a href="https://pro.benzinga.com/">check out Benzinga Pro. Try it for free.</a>
How does this stack up against Cleanspark's peers?
Investors may also want to analyze a stock in comparison to companies with similar products or in similar industries. Cleanspark operates in the Information Technology sector. The stock has experienced average annual growth of -6.81% compared to the -16.0% average of its peer companies. This is below the broader sector movement of Cleanspark.
CLSK Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, CleanSpark shares are up 7.27% at $9.48 at the time of publication Thursday. 
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40923038/whats-going-on-with-carnival-stock">What&#8217;s Going On With Carnival Stock?</a></li>
</ul>
Image: Roy Buri from Pixabay

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

CLSK

What's Going On With Bitcoin-Miner CleanSpark's Stock?

Northland Capital Markets analyst Mike Grondahl initiates coverage on HIVE Digital Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) with a Outperform rating and announces Price Target of $5.5.

Initiation

HIVE

Northland Capital Markets Initiates Coverage On HIVE Digital Technologies with Outperform Rating, Announces Price Target of $5.5

Grant Cardone is fired up about inflation and he's not holding back. In a recent post on X (formerly Twitter), the entrepreneur laid it out in blunt terms: "Print &amp; distribute money to stupid people who then spend it on stupid stuff they otherwise could not afford." According to him, this is exactly what's happening in the current economic climate.&nbsp;
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a></li>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
</ul>
Cardone's frustration is clear. He believes the government is setting people up for failure by printing more money and not teaching financial literacy. "Until our gov't educates our citizens on financial literacy &amp; quits bailing them out, there will be slaves forever," he wrote. It's a harsh critique, but Cardone isn't known for mincing words.
He's also not shy about calling out the current administration. In a breakdown of inflation by administration, Cardone<a href="https://www.benzinga.com/real-estate/24/09/40818098/grant-cardones-inflation-breakdown-40-energy-cost-hike-marks-biden-harris-economic-impact"> highlighted a 40.2% increase in energy costs under President Joe Biden,</a> compared to a negative 0.7% during Donald Trump's term. To Cardone, this spike in energy prices is just one example of how the Biden-Harris policies are hurting the middle class. "You want more of this insanity?" he asked his followers in a previous post. "Harris will destroy the middle class."
Trending: Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a>
Cardone's post didn't just throw numbers out there without context. He pointed to the Biden administration's focus on transitioning to renewable energy and stricter fossil fuel regulations as key drivers behind the rising energy costs. While he's all for innovation, Cardone argues that the policies are creating unnecessary financial burdens for everyday Americans.
But not everyone agrees with Cardone's take. Some of his followers questioned the accuracy of the data he posted. One user, "Biden's Debt Monster," pointed out that the numbers need more context, especially considering Trump's term ended during the pandemic. Another follower, Grant Goode, went even further, calling Cardone's post "deceptive" and arguing that Trump's massive spending contributed to the current economic situation.
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
Cardone's response? Silence on the critique but continuing his push for financial education. To him, the real issue is deeper than just numbers. It's about how <a href="https://www.benzinga.com/personal-finance/24/08/40554281/the-razzle-dazzle-is-a-sham-grant-cardone-says-he-grew-up-in-the-democratic-party-but-now-sees-t">people are being set up to fail financially</a>. He's adamant that until Americans learn how to manage their money better – and stop relying on government handouts – things won't improve.
Cardone's blunt message is clear: Inflation isn't just a political issue; it's a personal one. And if people don't get smart about their money, they'll keep falling into the same traps.
Read Next:
<ul>
<li>The number of ‘401(k)' Millionaires is up 43% from last year —<a href="https://www.benzinga.com/money/401k-millionaires"> Here are three ways to join the club.</a></li>
<li><a href="https://www.benzinga.com/money/charlie-munger-100k">Charlie Munger said if you want to be rich, &#8220;find a way to get your hands on $100,000&#8221; — here&#8217;s what he means.</a></li>
</ul>

Personal Finance

Grant Cardone Slams Inflation: 'Print & Distribute Money To Stupid People Who Spend It On Stupid Stuff'

Goldman Sachs analyst Duffy Fischer maintains Tronox Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) with a Buy and lowers the price target from $18 to $16.

TROX

Goldman Sachs Maintains Buy on Tronox Holdings, Lowers Price Target to $16

Trump Media & Technology Group shares are trading lower, possibly amid the expiration of the lockup period that prevents large shareholders, such as Donald Trump, from selling stocks. Also, 2024 Presidential polls show that Donald Trump is behind rival candidate, Vice President Harris.

Cracker Barrel Old Country Store, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) reported fourth-quarter adjusted earnings per share of 98 cents, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/n40936522/cracker-barrel-reports-fourth-quarter-fiscal-2024-results" rel="noreferrer noopener">missing the street view of $1.10. </a>Quarterly sales of $894.39 million (+6.9%), missing the analyst consensus of $897.22 million.
For the fourth quarter of fiscal 2024, total revenue includes a $62.8 million boost from the 53rd week.
Cracker Barrel&#8217;s comparable store restaurant sales rose by 0.4%, driven by total menu price increases of 4.2%.
However, comparable store retail sales fell by 4.2% compared to the same quarter last year.
Adjusted EBITDA&nbsp;was&nbsp;$57.4 million, or&nbsp;6.4%&nbsp;of total revenue versus $70.4 million, or&nbsp;8.4%&nbsp;of total revenue in the same period a year earlier.
The company announced that it has approved a quarterly dividend of $0.25 per share on its common stock. This dividend will be payable on November 13 to shareholders recorded as of October 18.
Outlook: Cracker Barrel projects FY25 total revenue between $3.4 billion and $3.5 billion, <a href="https://www.benzinga.com/calendars/guidance">compared to the $3.474 billion estimate.</a>
Cracker Barrel plans to open two new stores and three to four new Maple Street Biscuit Company units.
The company anticipates commodity inflation of 2% to 3% and hourly wage inflation of 3% to 4% compared to the previous year. It projects adjusted EBITDA between $200 million and $215 million, with capital expenditures ranging from $160 million to $180 million.
Price Action: CBRL shares are trading lower by 0.67% to $41.28 at last check Thursday.
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40937841/jim-cramer-this-utilities-stock-is-a-buy-calls-wells-fargo-a-winner" target="_blank" rel="noreferrer noopener">Jim Cramer: This Utilities Stock Is A Buy, Calls Wells Fargo A &#8216;Winner&#8217;</a></li>
</ul>

Earnings

Equities

Guidance

CBRL

Cracker Barrel Battles Inflation, Eyes Expansion Amid Q4 Earnings Miss

Rumors

BNTX

Watching BioNTech; Traders Circulating Stock Picked By Popular Retail Trading Newsletter

Goldman Sachs analyst John Mackay maintains Targa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) with a Buy and raises the price target from $147 to $163.

TRGP

Goldman Sachs Maintains Buy on Targa Resources, Raises Price Target to $163

Endava PLC&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dava#NYSE">DAVA</a>) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.71 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -3.45%. A quarter ago, it was expected that this company would post earnings of $0.23 per share when it actually produced earnings of $0.28, delivering a surprise of 21.74%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Endava, which belongs to the Zacks Computers - IT Services industry, posted revenues of $245.3 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 1.35%. This compares to year-ago revenues of $237.56 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Endava shares have lost about 62.9% since the beginning of the year versus the S&amp;P 500&#39;s gain of 17.8%.
<h2>What&#39;s Next for Endava?</h2>
While Endava has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Endava: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.38 on $257.42 million in revenues for the coming quarter and $1.60 on $1.06 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computers - IT Services is currently in the top 20% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Accenture (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/acn#NYSE">ACN</a>), another stock in the same industry, has yet to report results for the quarter ended August 2024. The results are expected to be released on September 26.
This consulting company is expected to post quarterly earnings of $2.77 per share in its upcoming report, which represents a year-over-year change of +2.2%. The consensus EPS estimate for the quarter has been revised 0% higher over the last 30 days to the current level.
Accenture&#39;s revenues are expected to be $16.33 billion, up 2.2% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2338368/endava-plc-sponsored-adr-dava-misses-q4-earnings-and-revenue-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2338368">To read this article on Zacks.com click here.</a>

Earnings Misses

Large Cap

Small Cap

Tech

DAVA

Endava PLC Misses Q4 Earnings and Revenue Estimates

Goldman Sachs analyst Ati Modak maintains MYR Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYRG#NASDAQ">MYRG</a>) with a Buy and lowers the price target from $182 to $124.

MYRG

Goldman Sachs Maintains Buy on MYR Group, Lowers Price Target to $124

California Hospital Receives Robot Upgrade
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.knightscope.com%2F&amp;esheet=54124704&amp;newsitemid=20240919470351&amp;lan=en-US&amp;anchor=Knightscope%2C+Inc.&amp;index=1&amp;md5=ead5fafeedc285e9b59834e8c11d0b13">Knightscope, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) ("Knightscope" or the "Company"), an innovator in robotics and artificial intelligence ("AI") technologies focused on public safety, today announces another security robot contract renewal in Texas and a robot upgrade for a California hospital.
 &nbsp;

KSCP

Knightscope Announces Another Security Robot Contract Renewal In Texas And A Robot Upgrade For A California Hospital

Goldman Sachs analyst Caitlin Burrows maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Sell and raises the price target from $13 to $14.6.

Goldman Sachs Maintains Sell on Macerich, Raises Price Target to $14.6

Goldman Sachs analyst Mike Burton maintains Cinemark Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) with a Sell and raises the price target from $16 to $20.

Goldman Sachs Maintains Sell on Cinemark Hldgs, Raises Price Target to $20

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a pharmaceutical firm focused on central nervous system disorders, has launched a clini...

SciSparc Initiates Groundbreaking Autism Therapy Trial

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd. invites its shareholders to attend the Annual General Meeting on October 1, 2024, in Tel...

SciSparc Ltd. Calls for Crucial Shareholder Votes

Trials for psychedelic drug candidate for PTSD under scrutiny by FDA - report

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a pharmaceutical firm specializing in central nervous system disorders, has announced t...

SciSparc Advances Tourette Syndrome Drug Trial

SciSparc files to sell 21M ordinary shares for holders

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a pharmaceutical company specializing in central nervous system disorders, has revealed...

SciSparc and Clearmind Innovate in Mental Health Therapy

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., in collaboration with Clearmind Medicine Inc., has announced the publication of an inte...

SciSparc and Clearmind Innovate Mental Health Treatment

SciSparc extends additional loan of $1.85M to AutoMax

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a clinical-stage pharmaceutical company, has provided an additional $1.85 million loan ...

SciSparc Funds AutoMax, Secures Import Deal

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a clinical-stage pharmaceutical company, and Clearmind Medicine Inc. have published an ...

SciSparc Unveils Breakthrough Ibogaine Therapy Patent

ATAI

ATNF

CMPS

CYBN

DRUG

ENVB

GHRS

MNMD

SEEL

SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome

Legal

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Contracts

SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax's Direct Import Agreement with Major Chinese Vehicle Manufacturer

SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

CSE:CMND

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

SciSparc

SciSparc (SPRC) Forecast

SciSparc (NASDAQ:SPRC) Stock, Quote.Headers.trade-ideas